期刊文献+

姜黄素对口腔鳞癌SCC-25细胞EGFR信号通路表达的影响 被引量:8

Curcumin Inhibits Human Oral Cancer Cell Growth by Suppressing EGFR Phosphorylation
下载PDF
导出
摘要 目的:探讨姜黄素对口腔鳞癌SCC-25细胞EGFR信号通路表达的影响及其相关的分子机制。方法:不同浓度姜黄素作用细胞24 h,MTT法检测姜黄素对细胞增殖作用的影响,Transwell实验检测EGF和姜黄素共同作用下细胞侵袭能力的变化,Western blot检测姜黄素对SCC-25细胞EGFR活性及下游信号分子(Akt、ERK1/2和STAT3)表达的影响。结果:不同浓度姜黄素作用SCC-25细胞24 h后,均可抑制SCC-25细胞增殖,亦可以抑制EGF诱导的细胞侵袭转移。Western blot结果显示姜黄素对SCC-25细胞总EGFR表达无影响,但可以剂量依赖性抑制SCC-25细胞p-EGFR表达,同时可以剂量依赖性抑制EGFR信号通路下游转录因子Akt、ERK1/2和STAT3磷酸化。结论 :姜黄素可剂量依赖性抑制SCC-25细胞EGFR磷酸化活性及其下游信号通路分子(Akt、ERK1/2、STAT3)的磷酸化。 Objective:To study whether Curcumin was associated with the signaling pathway expression of EGFR of hu-man oral squamous cell carcinoma (OSCC) SCC-25 cells and its molecular mechanisms. Methods:The efficacy of curcum-in on proliferation in SCC-25 cell line were investigated. The inhibition effect of curcumin on EGF-induced SCC-25 cells invasion were explored by transwell assay. The efficacy of curcumin on the activition of EGFR and its downstream sig-naling molecules Akt, ERK1/2 and STAT3 were investigated by western blot. Results: Curcumin inhibited SCC-25 cells proliferation and EGF-triggered SCC-25 cells invasion. Curcumin regulated the p-EGFR and EGFR downstream signal-ing molecules including Akt, ERK1/2 and STAT3. Conclusion: Curcumin reduced SCC-25 cells proliferation and inva-sion through inhibiting the phosphorylation of EGFR and EGFR downstream signaling molecules Akt, ERK1/2 and STAT3.
出处 《口腔颌面外科杂志》 CAS 2015年第5期326-329,共4页 Journal of Oral and Maxillofacial Surgery
关键词 EGFR信号通路 姜黄素 口腔鳞癌 靶向治疗 EGFR signaling pathways curcumin oral squamous cell carcinoma target therapy
  • 相关文献

参考文献13

  • 1孙黎波,郑光勇.口腔鳞癌诱导化疗的临床研究进展[J].口腔颌面外科杂志,2009,19(3):224-227. 被引量:7
  • 2Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013 [J]. CA Cancer J Clin , 2013, 63:11-30.
  • 3Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network[J]. Nat Rev Mol Cell Biol, 2001, 2(2):127-137.
  • 4Normanno N, Bianco C, De Luca A, et al. Target-based a- gents anainst ErbB receptors and their ligands: a novel ap- proach to cancer treatment[J]. Endocr Relat Cancer, 2003, 10(1):1-21.
  • 5Dai W, Li Y, Zhou Q, et al. Cetuximab inhibits oral squa- mous cell carcinoma invasion and metastasis via degrada- tion of epidermal growth factor receptor [J]. J Oral Pathol Med, 2014, 43(4):250-257.
  • 6Brusevold IJ, Aasrum M, Bryne M, et al. Migration in- duced by epidermal and hepatocyte growth factors in oral squamous carcinoma cells in vitro: role of MEK/ERK, p38 and PI-3 kinase/Akt [J]. J Oral Pathol Med, 2012, 41(7): 547-558.
  • 7Nakata Y, Uzawa N, Takahashi K, et al. EGFR gene copynumber alteration is a better prognostic indicator than protein overexpression in oral tongue squamous cell carci- nomas[J]. Eur J Cancer, 2011, 47(15):2364-2372.
  • 8Doumiati S, Haupt K, Rossi C. Autophosphorylation acti- vation and inhibition by curcumin of the epidermal growth factor receptor reconstituted in liposomes[J]. J Mol Recog- nit, 2012, 25(11):623-629.
  • 9Lin MC, Huang MJ, Liu CH, et al. GALNT2 enhances mi- gration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity[J]. Oral Oncol, 2014, 50(5):478-484.
  • 10Aquino G, Pannone G, Santoro A, et al. pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell car- cinoma: a tissue-mieroarray study with clinic-pathological correlations[J]. Cancer Biol Ther, 2012, 13(11):967-977.

二级参考文献20

  • 1屠规益.诱导化疗在头颈鳞癌综合治疗中的作用[J].中国口腔颌面外科杂志,2006,4(3):162-165. 被引量:16
  • 2Barone C, Grillo R, Dongiovanni D, et al. Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma [J]. Anticancer Res,2008,28(2B): 1285-1291.
  • 3Eckardt A, Rades D, Rudat V, et ah Prospective phase Ⅱ study of neoadjuvant radiochemotherapy in advanced operable carcinoma of the mouth cavity. 3-year outcome[J]. Mund Kiefer Gesichtschir,2002, 6(2):117-121.
  • 4Nakazawa M, Ohnishi T, Ohmae M, et al. Phase Ⅱ study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma[J]. Int J Clin Pharmacol Res, 2005,25(3):115-122.
  • 5Giralt JL, Gonzalez J, del Campo JM, et al. Preoperative induction chemotherapy followed by concurrent chemoradiotherapy in advanced carcinoma of the oral cavity and oropharynx[J]. Cancer, 2000,89(5) : 939-945.
  • 6Faivre S, Marti A, Rixe O, et al. Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of the head and neck[J]. Head Neck,2005,27(4):311- 319.
  • 7Kessler P, Grabenbauer G, Leher A, et al. Five year survival of patients with primary oral squamous cell carcinoma.Comparison of two treatment protocols in a prospective study[J]. Strahlenther Onkol, 2007,183(4): 184-189.
  • 8Kurita H, Koike T, Miyazawa H, et al. Retrospective analysis on prognostic impact of adjuvant chemotherapy in the patients with advanced and resectablc oral squamous cell carcinoma[J]. Gan To Kagaku Ryoho,2006, 33(7):915-921.
  • 9Klug C, Wutzl A, Kermer C, et al. Preoperative radiochemotherapy and radical resection for stages Ⅱ-Ⅳ oral and oropharyngeal cancer: outcome of 222 patients[J]. Int J Oral Maxillofac Surg, 2005, 34(2): 143-148.
  • 10Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer[J]. N Engl J Med, 2007,357(17):1705-1715.

共引文献6

同被引文献92

引证文献8

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部